or Try an Advanced Search...

    Technical Analysis for AVIR - Atea Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 3.65 -1.35% -0.05
    AVIR closed down 1.35 percent on Friday, May 17, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical AVIR trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish -1.35%
    Calm After Storm Range Contraction -1.35%
    Inside Day Range Contraction -1.35%
    Down 3 Days in a Row Weakness -1.35%
    Older End-of-Day Signals for AVIR ...

       Recent Intraday Alerts

    Alert Time
    Outside Day 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 1% 1 day ago
    Possible NR7 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AVIR Chart by TradingView
    Basic chart:

    Profile

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is AVIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
    May 15 Atea Pharmaceuticals, Inc. (AVIR) Q1 2024 Earnings Call Transcript
    May 14 Atea Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 14 Atea Pharmaceuticals GAAP EPS of -$0.75 misses by $0.14
    May 14 Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
    May 7 Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
    Apr 29 Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
    Mar 27 Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
    Feb 29 Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript
    Feb 29 Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript
    See more AVIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.19
    52 Week Low 2.765
    Average Volume 292,679
    200-Day Moving Average 3.49
    50-Day Moving Average 3.86
    20-Day Moving Average 3.82
    10-Day Moving Average 3.88
    Average True Range 0.14
    RSI (14) 39.39
    ADX 20.04
    +DI 22.45
    -DI 20.44
    Chandelier Exit (Long, 3 ATRs) 3.73
    Chandelier Exit (Short, 3 ATRs) 4.06
    Upper Bollinger Bands 4.07
    Lower Bollinger Band 3.56
    Percent B (%b) 0.17
    BandWidth 13.26
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0178
    Fundamentals Value
    Market Cap 304.54 Million
    Num Shares 83.4 Million
    EPS -1.57
    Price-to-Earnings (P/E) Ratio -2.32
    Price-to-Sales 1.90
    Price-to-Book 0.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.82
    Resistance 3 (R3) 3.83 3.79 3.79
    Resistance 2 (R2) 3.79 3.75 3.79 3.78
    Resistance 1 (R1) 3.72 3.73 3.70 3.71 3.77
    Pivot Point 3.68 3.68 3.67 3.68 3.68
    Support 1 (S1) 3.61 3.64 3.59 3.59 3.53
    Support 2 (S2) 3.57 3.62 3.56 3.52
    Support 3 (S3) 3.50 3.57 3.51
    Support 4 (S4) 3.48